KAYAK
Neurocrine Biosciences, Inc.
Mark For: KAYAK™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90272634 |
| Mark Literal Elements | KAYAK |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Service Mark |
| Current Location | NEW APPLICATION PROCESSING 2020-10-26 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Allison Strickland Ricketts |
| Attorney Docket Number | NEUB 2010605 |
Timeline
| 2020-10-22 | Application Filed |
| 2020-10-26 | Location: NEW APPLICATION PROCESSING |
| 2020-10-26 | Status: Live/Pending |
| 2020-10-26 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
| 2020-10-26 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Neurocrine Biosciences, Inc. |
| Address | 12780 El Camino Real San Diego, CALIFORNIA UNITED STATES 92130 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | MULTI | 2020-10-22 |
 Drawing | JPEG | 2020-10-22 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-10-26 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 